Cite
Vallejo C, Bianco A, Perez J, et al. Randomized trial comparing adriamycin vincristine (av) cyclophosphamide methotrexate 5-Fluorouracil prednisone (cmfp) hybrid versus av-cmfp monthly alternated in metastatic breast-cancer. Int J Oncol. 1993;2(3):437-42doi: 10.3892/ijo.2.3.437.
Vallejo, C., Bianco, A., Perez, J., Machiavelli, M., Leone, B., Romero, A., Rabinovich, M., Alvarez, L., Rodriguez, R., Cuevas, M., Hannois, A., & Lacava, J. (1993). Randomized trial comparing adriamycin vincristine (av) cyclophosphamide methotrexate 5-Fluorouracil prednisone (cmfp) hybrid versus av-cmfp monthly alternated in metastatic breast-cancer. International journal of oncology, 2(3), 437-42. https://doi.org/10.3892/ijo.2.3.437
Vallejo, C, et al. "Randomized trial comparing adriamycin vincristine (av) cyclophosphamide methotrexate 5-Fluorouracil prednisone (cmfp) hybrid versus av-cmfp monthly alternated in metastatic breast-cancer." International journal of oncology vol. 2,3 (1993): 437-42. doi: https://doi.org/10.3892/ijo.2.3.437
Vallejo C, Bianco A, Perez J, Machiavelli M, Leone B, Romero A, Rabinovich M, Alvarez L, Rodriguez R, Cuevas M, Hannois A, Lacava J. Randomized trial comparing adriamycin vincristine (av) cyclophosphamide methotrexate 5-Fluorouracil prednisone (cmfp) hybrid versus av-cmfp monthly alternated in metastatic breast-cancer. Int J Oncol. 1993 Mar;2(3):437-42. doi: 10.3892/ijo.2.3.437. PMID: 21573574.
Copy
Download .nbib